临床试验登记· Second Affiliated Hospital of Wenzhou Medical University · ClinicalTrials.gov·· 21 小时前评分33
adebrelimab联合trametinib治疗儿童及青少年难治性复发性朗格汉斯细胞组织细胞增生症的单臂多中心II期临床试验
A Single-Arm,Multicenter Phase, Phase II Clinical Trial of Adebrelimab Combined With Trametinib in the Treatment of Refractory Recurrent Langerhans Cell Histiocytosis in Children and Adolescents
导读
NCT07890701登记adebrelimab联合trametinib治疗儿童及青少年难治性复发性LCH的单臂多中心II期临床试验。试验由温州医科大学附属第二医院申办，计划邀请2人入组。既往2例儿童观察显示方案安全性与耐受性良好且均有临床获益，仍需扩大样本验证疗效。
来源：临床试验登记 · clinicaltrials.gov